Characterization of Hap/BAG-1 variants as RP1 binding proteins with antiapoptotic activity

• Verfasst von: Wadle, Andreas [VerfasserIn]
• Verfasst von: Henrich, Philipp Peter [VerfasserIn]
• Verfasst von: Petersen, Gabriele [VerfasserIn]
• Titel: Characterization of Hap/BAG-1 variants as RP1 binding proteins with antiapoptotic activity
• Verf.angabe: Andreas Wadle, Axel Mischo, Philipp P. Henrich, Frank Stenner-Lieven, Christoph Scherer, Jochen Imig, Gabriele Petersen, Michael Pfreundschuh, Christoph Renner
• Umfang: 8 S.
• Fussnoten: Gesehen am 06.06.2017
• Titel Quelle: Enthalten in: International journal of cancer
• Jahr Quelle: 2005
• Band/Heft Quelle: 117(2005), 6, S. 896-904
• ISSN Quelle: 1097-0215
• DOI: doi:10.1002/ijc.21259
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1559467177

Abstract

The MAPRE protein family (EB1, RP1, EB2) represents a highly conserved group of proteins that localize preferentially to the plus end of microtubules, both in the nucleus and cytoplasm. In addition, MAPRE family members are characterized by their capability to bind to the C-terminus of the adenomatous polyposis coli (APC) protein and tubulin in order to stabilize microtubules. Apart from the interaction with APC and tubulin, no other direct binding partners are known today. Because the RP1 gene product was identified in activated T cells, we set out to search for new interacting molecules in a yeast 2-hybrid system. We isolated a cDNA variant encoding for the antiapoptotic Hap/BAG-1 protein truncated by 34 amino acids at the C-terminus. In the original Hap/BAG-1 protein, the C-terminal domain is responsible for binding to Bcl-2 and Hsp/Hsc70, which is believed to be the reason for its antiapoptotic activity. Although this putative Hap/BAG-1 variant protein showed no interaction with Bcl-2 or Hsp/Hsc70, it was perfectly able to confer resistance to apoptosis. Subcellular distribution analysis revealed that the Hap/Bag-1 variant protein localized homogenously to the cytoplasm and shuttles into the nucleus in response to stress, a process that could be blocked by RP1 protein overexpression. © 2005 Wiley-Liss, Inc.